- Product Details
Keywords
- Hydrocortisone acetate
- Hydrocortisone acetate high purity
- Cortisol acetate
Quick Details
- ProName: CAS:50-03-3 Hydrocortisone acetate
- CasNo: 50-03-3
- Molecular Formula: C23H32O6
- Appearance: White powder
- Application: Medicine
- DeliveryTime: within 3-4days after received your pay...
- PackAge: according to customers' requirements
- Port: all chinese port
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99.5%
- Storage: store in cool and dry
- Transportation: by sea or by air
- LimitNum: 1 Kilogram
Superiority
1.Hydrocortisone acetate
2.CAS:50-03-3
3.EP7 GMP DMF COS
4.Appearance:A white or almost white crystalline powder
5.Certificate of analysis:
ITEMS |
SPECIFICATION |
RESULTS |
CHARACTERS |
A WHITE OR ALMOST WHITE, CRYSTALLINE POWDER |
WHITE CRYSTALLINE POWDER |
SOLUBILITY |
PRACTICALLY INSOLUBLE IN WATER, SPARINGLY SOLUBLE IN ETHANOL AND IN METHYLENE CHLORIDE |
COMPLIES |
MELTING POINT(PH.EUR.) |
ABOUT 220°C |
223°C |
IDENTIFICATION |
||
A.IR-SPECTRUM(PH.EUR) |
MEETS THE REQUIREMENT |
COMPLIES |
B.TLC(PH.EUR) |
MEETS THE REQUIREMENT |
COMPLIES |
A.IR-SPECTRUM(USP) |
MEETS THE REQUIREMENT |
COMPLIES |
B.UV ABSORPTION(USP) |
MEETS THE REQUIREMENT |
COMPLIES |
SPECIFIC ROTATION |
||
(PH.EUR) |
BETWEEN+158°AND +167° |
+164.7° |
(USP) |
BETWEEN+158°AND +165° |
+160.3° |
LOSS ON DRYING |
||
(PH.EUR) |
NOT MORE THAN 0.5% |
0.21% |
(USP) |
NOT MORE THAN 1.0% |
0.16% |
RESIDUE ON IGNITION(USP) |
NEGLIGIBLE,FROM 100mg |
COMPLIES |
RELATED SUBSTANCES(PH.EUR) |
||
ANY INDIVIDUAL IMPURITY |
NOT MORE THAN 1.0% |
0.16% |
SUM OF IMPURITIES |
NOT MORE THAN 1.5% |
0.55% |
CHROMATOGRAPHIC PURITY(USP) |
||
ANY INDIVIDUAL IMPURITY |
NOT MORE THAN 1.0% |
0.12% |
SUM OF IMPURITIES |
NOT MORE THAN 2.0% |
0.64% |
RESIDUAL SOLVENT(IN-HOUSE) |
||
ETHANOL |
NOT MORE THAN 2000PPM |
817PPM |
DMF |
NOT MORE THAN 880PPM |
N.D. |
ASSAY |
||
(PH.EUR) |
BETWEEN 97.0% AND 103.0% |
100.6% |
(USP) |
BETWEEN 97.0% AND 102.0% |
100.6% |
PARTICLE SIZE(IN-HOUSE) |
90% NOT MORE THAN 20 MICRONS |
COMPLIES |
CONCLUSION:THE PRODUCT CONFORMS TO PH.EP.6 |
6.USE:
It is mainly used to treat rheumatoid arthritis, rheumatic fever, gout, bronchial asthma. Injection for tuberculous or fester sex meningitis, tuberculosis pleurisy, pyothorax, arthritis, tenosynovitis, tendons strain, sprains, nodular rash, itching flat moss, etc. Eye drops agent used in all kinds of eye inflammation. Frost agent in allergic or seborrheic dermatitis, itch disease, etc.
Details
Kono Chem Co.,Ltd is a leading producer of standardized herbal extracts, natural active ingredients and APIs for pharmaceutical, health food and cosmetic industries.
The botanical raw materials are subject to strict selection and inspection, and extracts are manufactured according to methods developed by Pioneer. They include inspections to guarantee a high quality standard from both analytico-chemical and therapeutic points of view, and take into consideration the state of art in different fields: research and development, analyses, processes and machinery, therapeutic applications on a scientific basis.
With our phytopharmaceutical background and knowledge through experience, PIONEER can also provide a wide range of analytical services and reference substances to our clients. In addition, We also manufacture pharmaceutical raw materials of nucleotide species, mainly including as below: SAM-e Tosylate Disulfate; SAM-e 1,4-Butanedisulfonate; Polycytidylic Acid; Polyinosinic Acid; Adenosine Triphosphate Disodium; and Cytidine Triphosphate Disodium; these items are our strongest advantage in China. Meanwhile, we can do custom made pharmaceutical ingredients depending on our professional experts in the pharmaceutical and chemistry industry.
Recently, Kono Chem has been working hard on the research and development of new cardiovascular and anesthesia drugs, we have got good achievements; moreover, we also offer natural anticancer drugs and other pharmaceutical intermediates. As a GMP standardized manufacturer, our products can meet or even exceed the standards of CP2010, USP32, BP2005 and EP4. Presently, 80% and above of our products have been well-recognized in dozens of countries and regions, such as USA, EU, South America and Southeast Asia. There are experienced technicians working for our institutes now, all of them are skilled. Pioneer is looking forward to cooperating with friends all over the world for getting collaborative development; we are willing to work with you to develop new drugs and expand new business, let's work together for bright future.